Hemodynamic changes and quality of life in patients with prostate cancer after a HIIT and MICT training. A randomized clinical trial (ONCO-EXE TRIAL)
DOI:
https://doi.org/10.15381/anales.v80i4.16218Keywords:
Neoplasias de la Próstata, Calidad de Vida, Rehabilitación Cardiaca, Ejercicio, Entrenamiento de Resistencia, Ensayo ClínicoAbstract
Introduction. Prostate cancer is the most common in men and is the second cause of death. Exercise-based rehabilitation is effective and safe in mitigating cancer effects. Objective. To determine the hemodynamic changes and quality of life in prostate cancer after a high intensity training (HIIT) or continuous to moderate intensity (MICT). Methods. A randomized clinical trial with 249 patients with stage II prostate cancer divided into 3 groups (MICT, HIIT and control group) who were applied EORTC QLQ C-30 questionnaire for quality of life, echocardiogram, stress test, vital signs and FACT-Fatigue Scale. The training program lasted 36 sessions of 70 minutes, 3 times a week. Results. When comparing the post-training results of the hemodynamic variables, we managed to determine changes in the ejection fraction (GE1: 49.0 ± 5.6 vs 52.0 ± 5.4, GE2: 45.0 ± 5.3 vs 51.0 ± 3.2, GC: 48.0 ± 4.1 vs 48.0 ± 4.4 p<0.005), maximum heart rate (GE1: 155.0 ± 7.0 vs 159.0 ± 4.0, GE2: 156.0 ± 14.0 vs 168.0 ± 5.0, GC: 155.0 ± 7.0 vs 155 ± 6.0, p<0.005). As in the results for quality of life (GE1: 55.1 ± 10.3 vs 70.9 ± 10.2, GE2: 59.8 ± 9.9 vs 118.0 ± 14.6, GC: 60.2 ± 7.6 vs 62.3 ± 9.4, p<0.005). Conclusions. HIIT and MICT significantly improved the quality of life, fatigue, and all hemodynamic variables evaluated in the research. Greater benefits were demonstrated with HIIT. The usual care control group without physical training did not show significant changes.
Downloads
Published
Issue
Section
License
Copyright (c) 2019 Anales de la Facultad de Medicina
![Creative Commons License](http://i.creativecommons.org/l/by-nc-sa/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Those authors who have publications with this magazine accept the following terms:
- Authors will retain their copyrights and guarantee the journal the right of first publication of their work, which will be simultaneously subject to Creative Commons Attribution License that allows third parties to share the work as long as its author and its first publication this magazine are indicated.
- Authors may adopt other non-exclusive licensing agreements for the distribution of the version of the published work (eg, deposit it in an institutional electronic file or publish it in a monographic volume) provided that the initial publication in this magazine is indicated.
- Authors are allowed and recommended to disseminate their work over the Internet (eg: in institutional telematic archives or on their website) before and during the submission process, which It can produce interesting exchanges and increase quotes from the published work. (See El efecto del acceso abierto ).